NEOPHARM
The computed 12-month bankruptcy probability of NEOPHARM is 3.7% (moderate). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 3 yrs |
| Locations | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro | 23-03-2026 | 2026-00061341 |
| 31-12-2024 | micro | 23-08-2025 | 2025-00436974 |
| 31-12-2023 | micro | 31-08-2024 | 2024-00421714 |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 28-10-2022 |
| Status | Active |
| Postal code | 1090 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21010B0052/00F000 | Brussels | 4.1 ha | 1 · 1,175 m² | 79.0 m · 25 fl. |
| 23084A0125/00F002 | Flanders | 377 m² | 1 · 101 m² | 5.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | NEOPHARM |